Dr. Gerald Batist

Anti-cancer treatment is now under way with a highly sophisticated and versatile linear accelerator that’s newly installed at the JGH.

A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.

A major donation has led to creation of a JGH-based consortium to improve the outcomes of lung cancer patients through customized treatments.

The Segal Cancer Centre at the JGH has responded to COVID-19 with compassion and innovation by enabling patients can consult with oncologists by video as an alternative to face-to-face meetings.

Dr. Gerald Batist, Director of the Segal Cancer Centre and Deputy Director of the Lady Davis Institute at the JGH, has received the 2019 Award for Exceptional Leadership in Cancer Research from the Canadian Cancer Research Alliance.

In 1981, Hope & Cope was launched under the auspices of the JGH Auxiliary to use specially trained volunteers (many of whom were cancer survivors) to support and counsel cancer patients and their families.

It is with deep sorrow that we mourn the sudden and tragic passing of Dr. Mark A. Wainberg, one of the world’s pre-eminent experts on HIV/AIDS and its treatment.

The Segal Cancer Centre is taking “one small step” that could lead to “one giant leap” in a metaphorical moonshot to conquer cancer.

Canadian and Israeli strategies for controlling budgets and reducing waiting times were compared and explored on November 23, 2016, during a visit to the JGH by Rabbi Yaakov Litzman, Israel’s Minister of Health.

In the space of just a few months this past spring, Dr. Gerald Batist was appointed a Member of the Order of Canada and a Knight of the National Order of Quebec.